{"id":10201,"date":"2014-02-20T15:21:50","date_gmt":"2014-02-20T23:21:50","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/?p=10201"},"modified":"2017-04-25T04:17:00","modified_gmt":"2017-04-25T11:17:00","slug":"pioneering-cell-therapy-achieves-complete-remission-in-patients-with-end-stage-leukemia","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2014\/02\/pioneering-cell-therapy-achieves-complete-remission-in-patients-with-end-stage-leukemia","title":{"rendered":"Pioneering Cell Therapy Achieves Complete Remission In Patients With End-Stage Leukemia"},"content":{"rendered":"<p>Written By: <a title=\"Posts by Cameron Scott\" href=\"http:\/\/singularityhub.com\/author\/cscott\/\" rel=\"author\">Cameron Scott<\/a> \u2014 Singularity Hub<br \/>\n<br \/> There are certain words that you would never want to hear coming from a healthcare provider. \u201cSalvage chemotherapy\u201d and \u201cHail Mary transplant\u201d would rank high on that list for most of us.<\/p>\n<p>And yet it was patients who weren\u2019t even eligible for these treatments or for whom they\u2019d already failed who participated in a recent clinical trial for a cell therapy treatment for adult B-cell acute lymphoblastic leukemia, or B-ALL, led by Michel Sadelain at <a href=\"http:\/\/www.mskcc.org\/\">Memorial Sloan Kettering Cancer Center<\/a>.<\/p>\n<p>Nearly 90 percent achieved complete remission of the disease, the researchers reported today in <em>Science Translational Medicine<\/em>.<\/p>\n<p><a href=\"http:\/\/singularityhub.com\/2014\/02\/19\/pioneering-cell-therapy-achieves-complete-remission-in-patients-with-end-stage-leukemia\/\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Written By: Cameron Scott \u2014 Singularity Hub There are certain words that you would never want to hear coming from a healthcare provider. \u201cSalvage chemotherapy\u201d and \u201cHail Mary transplant\u201d would rank high on that list for most of us. And yet it was patients who weren\u2019t even eligible for these treatments or for whom they\u2019d [\u2026]<\/p>\n","protected":false},"author":76,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-10201","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/10201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/76"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=10201"}],"version-history":[{"count":1,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/10201\/revisions"}],"predecessor-version":[{"id":47222,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/10201\/revisions\/47222"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=10201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=10201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=10201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}